| MR编号 | DE/H/0468/002 |
|---|
| 药品名称 | Priorix-Tetra,
powder and solvent for solution for injection |
|---|
| 活性成分 | - Measles virus, live attenuated 3.0 log10 CCID50
- Mumps virus, live attenuated 4.4 log10 CCID50
- Rubella virus, live attenuated 3.0 log10 CCID50
- Varicella virus, live attenuated 3.3 log10 CCID50
|
|---|
| 剂型 | Powder and solvent for solution for injection |
|---|
| 上市许可持有人 | GlaxoSmithKline GmbH & Co. KG
Prinzregentenplatz 9
81675 München
Germany |
|---|
| 参考成员国 - 产品名称 | Germany (DE) |
|---|
| 互认成员国 - 产品名称 | - Norway (NO)
- Estonia (EE)
- Italy (IT)
- Latvia (LV)
- Lithuania (LT)
- Hungary (HU)
- Malta (MT)
- Ireland (IE)
|
|---|
| 许可日期 | 2007/05/10 |
|---|
| 最近更新日期 | 2024/12/12 |
|---|
| 药物ATC编码 | - J07BD54 measles, combinations with mumps, rubella and varicella, live attenuated
|
|---|
| 申请类型 | - TypeLevel1：Known Active Substance
- TypeLevel2：Initial Application
- TypeLevel3：Full Dossier Art 8.3(i) Dir 2001/83/EC
- TypeLevel4：Biological: Vaccine
- TypeLevel5：Prescription Only
|
|---|
| 附件文件下载 | |
|---|
| 市场状态 | Positive |
|---|